Reaktion #217631
ord-578a764c98ce48abb55509723bb9dcd0
Reaktionsgleichung
Edukte
Reaktionsbedingungen
Aufarbeitung
- 1workup.STIRRINGthe mixture stirred in a microwave (set at high absorbance) at 100° C. for a further 45 minutes
- 2SonstigeThe solvent was evaporated with addition of a few drops of toluene
- 3Wascheneluting with methanol
- 4Sonstigethe solvent evaporated
- 5SonstigeThe crude product was purified by mass
- 6Sonstigethe relevant fractions collected
- 7Sonstigesolvent evaporated
Vorschrift
To a mixture of 4-bromo-N-[5-(cis-3,5-dimethyl-1-piperazinyl)-2-(methyloxy)phenyl]-3-fluorobenzenesulfonamide (E105) (100 mg, 0.21 mmol) and 2-thienylboronic acid (54 mg, 0.42 mmol) in DME (3 ml) was added potassium tert-butoxide (212 mg, 1.89 mmol) and tetrakis(triphenylphosphine)palladium(0) (12 mg, 0.01 mmol) in water (1 ml) and the resulting mixture stirred in a microwave (set at high absorbance) at 100° C. for 30 minutes. Additional 2-thienylboronic acid (27 mg, 0.21 mmol) and tetrakis(triphenylphosphine)palladium(0) (12 mg, 0.01 mmol) were then added and the mixture stirred in a microwave (set at high absorbance) at 100° C. for a further 45 minutes. The solvent was evaporated with addition of a few drops of toluene and the residue passed through an SCX column eluting with methanol followed by 2M ammonia in methanol. The abasic fractions were combined and the solvent evaporated. The crude product was purified by mass directed autoprep HPLC, the relevant fractions collected and solvent evaporated to afford the title compound (E114). MS (ES+) m/e 476 [M+H]+.